|Initial Treatment with Sustiva and Kaletra
Jan 2, 2004
I tested positive in Oct 2003 with CD4 of 500 and viral load of 248,000. Doctor recommended immediate treatment. I am enrolled in a study, and was randomized to begin treatment with Sustiva (600mg) and Kaletra (4 pills twice daily) only. Initial results after 3 weeks are good (viral load <100,000) after initial severe rash, and I am a strict adherer to taking my meds and feel I always will be, but I am still very worried by what I read about treatment failure and future possiblities if I start on this treatment regiment. Am I unduely risking future options by starting on this combination? If so, is it safe to stop and switch to something more "conventional" to begin? Thanks!
| Response from Dr. Pierone
This regimen is very potent and if you have high level adherence it is not likely to fail. If you do run in to challenges with adherence, resistance will surely develop down the Sustiva pathway and would not compromise your options for protease inhibitors and nucleoside reverse transcriptase inhibitors. Just watch your lipid levels (cholesterol and triglycerides) on this combination. Good luck!
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Itchy Vagina After Swallowing Sperm Worried I Have HIV
- Night Sweats After Mutual Masturbation Sign Of HIV AIDS
- White Bumps On Penis After Touching Dried Semen Worried I Have HIV
- Can Bacterial Vaginosis Cause Vaginal Bleeding?
- Causes Of Clear Vaginal Discharge
- Std Irritation Inside Penis Antibiotics
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.